Application no. and date | 14862504.9 (espacenet) (Federated) (European Patent Register), 20141031 | Patent/reg. no. and date | DK/EP 3068392, 20210224 | Publication date | 20160921 | Priority no. and date | US 201361903010 P, 20131112, US 201461929604 P, 20140121, US 201462000659 P, 20140520 | EP pub. no. and date |
EP 3068392 20160921 | Effective date | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | Applicant ref. no. | P75787DK01 | Inventor | HURTER, Patricia, Nell, 49 Tahanto Trail
Harvard, MA 01451, US, SWINNEY, Kelly, Ann, 509 E. 2nd Street Unit 8
Boston, MA 02127, US, NADIG, David, E., 150 Dorchester Avenue Apt. 102
Dorchester, MA 02127, US, SMITH, David, 72 Parker Avenue
Newton, MA 02459, US, THOMAS, Vance, Hayden, 3 Pheasant Hill Lane
Duxbury, MA 02332, US, WARMAN, Martin, Paul, 1 Bradley Woods Drive
Hingham, MA 02043, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | Opponent | | IPC Class | A61K 31/443 (2006.01) , A61K 31/47 (2006.01) , A61K 45/06 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) | Title | FREMGANGSMÅDE TIL FREMSTILLING AF FARMACEUTISKE SAMMENSÆTNINGER TIL BEHANDLINGEN AF CFTR-MEDIEREDE SYGDOMME | Int. application no. | US2014063506 | Int. publication no. | WO2015073231 | Related patent (certificate) | | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|